Allergy Diagnostics Market Size, Share, Trends, Growth Outlook

Allergy Diagnostics Market is estimated to increase at a Compounded Annual Growth Rate of 12.4% CAGR over the forecast period from 2024 to 2030

The Allergy Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Consumables, Instruments, Services), By Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Others), By Test (In Vivo Tests, In Vitro Tests), By End-User (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Others).

An Introduction to Allergy Diagnostics Market in 2024

In the era of precision medicine, allergy diagnostics play a pivotal role in identifying allergens, characterizing immune responses, and guiding personalized treatment strategies for patients with allergic diseases. In 2024, allergy diagnostic technologies encompass a diverse array of testing modalities, including skin prick tests, blood tests (e.g., specific IgE assays), patch tests, and component-resolved diagnostics (CRD), each offering unique advantages in terms of sensitivity, specificity, and clinical utility. These tests enable healthcare providers to identify allergen sensitivities, assess disease severity, and tailor allergen immunotherapy regimens to individual patient profiles, optimizing therapeutic outcomes and minimizing adverse reactions. With advancements in molecular biology, bioinformatics, and allergen characterization, allergy diagnostics continue to evolve, offering new insights into allergic mechanisms, cross-reactivities, and treatment responses. As the prevalence of allergic diseases rises globally, allergy diagnostics remain essential tools in the allergist's armamentarium, facilitating accurate diagnosis and personalized management of allergic conditions to improve patient quality of life.

Market Trend: Expansion of Allergen Testing Panels and Molecular Diagnostics

One prominent trend in the allergy diagnostics market is the expansion of allergen testing panels and the adoption of molecular diagnostic techniques. As the understanding of allergic diseases evolves and the range of allergens expands, there is a growing demand for comprehensive testing panels that can identify a wide array of allergens, including common environmental allergens, food allergens, and specific allergen components. Molecular diagnostic methods such as polymerase chain reaction (PCR) and multiplex assays offer increased sensitivity and specificity in detecting allergen-specific IgE antibodies, enabling more accurate diagnosis and management of allergic conditions. This trend is driven by the need for personalized allergy testing approaches that can identify specific allergens triggering allergic reactions and guide targeted treatment strategies for individuals with allergies.

Market Driver: Rising Prevalence of Allergic Diseases and Environmental Sensitivities

A significant driver in the allergy diagnostics market is the rising prevalence of allergic diseases and environmental sensitivities. Allergic conditions such as allergic rhinitis, asthma, food allergies, and atopic dermatitis affect a significant portion of the global population, contributing to substantial healthcare costs, impaired quality of life, and productivity losses. Furthermore, increasing urbanization, pollution levels, and changes in lifestyle factors have led to heightened environmental sensitivities and allergic reactions, driving the demand for accurate and timely allergy diagnostics. The growing recognition of the burden of allergic diseases on public health and the economy underscores the importance of effective allergy testing and diagnosis in managing allergic conditions and improving patient outcomes.

Market Opportunity: Development of Point-of-Care Testing and Telemedicine Solutions

An emerging opportunity in the allergy diagnostics market is the development of point-of-care testing (POCT) and telemedicine solutions for allergy diagnosis and management. POCT devices enable rapid on-site detection of allergen-specific IgE antibodies, facilitating immediate diagnosis and treatment decisions in primary care settings, allergy clinics, and urgent care centers. Additionally, integrating allergy testing capabilities into telemedicine platforms enables remote consultation, virtual allergy assessments, and remote monitoring of allergic patients, particularly in underserved or remote areas where access to specialized allergy care may be limited. By leveraging POCT and telemedicine technologies, healthcare providers can improve access to allergy diagnostics, enhance patient convenience, and optimize allergy management strategies, ultimately improving patient outcomes and reducing the burden of allergic diseases on healthcare systems.

Allergy Diagnostics Market Share Analysis: In Vitro Tests is the fastest growing segment over the forecast period to 2030

Among the segments in the Allergy Diagnostics Market, the In Vitro Tests segment is experiencing rapid growth. This growth is primarily driven by several factors. Firstly, there's an increasing demand for more accurate and reliable allergy diagnostic methods, which has led to a preference for in vitro tests over traditional in vivo tests. In vitro tests offer several advantages, including greater sensitivity and specificity, reduced risk of adverse reactions, and the ability to analyze a wide range of allergens simultaneously. Additionally, advancements in technology have improved the precision and efficiency of in vitro testing methods, making them more appealing to both healthcare providers and patients. As the prevalence of allergies continues to rise globally, fueled by factors such as environmental changes and dietary habits, the demand for accurate and efficient allergy diagnostics is expected to propel the growth of the In Vitro Tests segment further.

Allergy Diagnostics Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossACON Laboratories Inc, AESKU.GROUP GmbH, Astra Biotech GmbH , bioMérieux SA, Danaher Corp, Erba Group., Eurofins Scientific SE, EUROIMMUN Medizinische Labordiagnostika AG, HOB Biotech Group Corp Ltd, HollisterStier Allergy LLC, HYCOR Biomedical Inc, Lincoln Diagnostics Inc, Minaris Medical America Inc, NEOGEN Corp, Omega Diagnostics Group PLC, R-Biopharm AG, Romer Labs Division Holding GmbH, Siemens Healthineers AG, Stallergenes Greer Ltd, Thermo Fisher Scientific Inc

Allergy Diagnostics Market Segmentation

By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Allergy Diagnostics Market Companies

ACON Laboratories Inc
AESKU.GROUP GmbH
Astra Biotech GmbH
bioMérieux SA
Danaher Corp
Erba Group.
Eurofins Scientific SE
EUROIMMUN Medizinische Labordiagnostika AG
HOB Biotech Group Corp Ltd
HollisterStier Allergy LLC
HYCOR Biomedical Inc
Lincoln Diagnostics Inc
Minaris Medical America Inc
NEOGEN Corp
Omega Diagnostics Group PLC
R-Biopharm AG
Romer Labs Division Holding GmbH
Siemens Healthineers AG
Stallergenes Greer Ltd
Thermo Fisher Scientific Inc

Reasons to Buy the Allergy Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Allergy Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Allergy Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Allergy Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Allergy Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Allergy Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Allergy Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Allergy Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Allergy Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Allergy Diagnostics Industry
4.2 Key Market Trends in Allergy Diagnostics Industry
4.3 Potential Opportunities in Allergy Diagnostics Industry
4.4 Key Challenges in Allergy Diagnostics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Allergy Diagnostics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Allergy Diagnostics Market Outlook by Segments
7.1 Allergy Diagnostics Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others

8 North America Allergy Diagnostics Market Analysis and Outlook To 2030
8.1 Introduction to North America Allergy Diagnostics Markets in 2024
8.2 North America Allergy Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Allergy Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others

9 Europe Allergy Diagnostics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Allergy Diagnostics Markets in 2024
9.2 Europe Allergy Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Allergy Diagnostics Market Size Outlook by Segments, 2021-2030
By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others

10 Asia Pacific Allergy Diagnostics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Allergy Diagnostics Markets in 2024
10.2 Asia Pacific Allergy Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Allergy Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others

11 South America Allergy Diagnostics Market Analysis and Outlook To 2030
11.1 Introduction to South America Allergy Diagnostics Markets in 2024
11.2 South America Allergy Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Allergy Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others
12 Middle East and Africa Allergy Diagnostics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Allergy Diagnostics Markets in 2024
12.2 Middle East and Africa Allergy Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Allergy Diagnostics Market size Outlook by Segments, 2021-2030
By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ACON Laboratories Inc
AESKU.GROUP GmbH
Astra Biotech GmbH
bioMérieux SA
Danaher Corp
Erba Group.
Eurofins Scientific SE
EUROIMMUN Medizinische Labordiagnostika AG
HOB Biotech Group Corp Ltd
HollisterStier Allergy LLC
HYCOR Biomedical Inc
Lincoln Diagnostics Inc
Minaris Medical America Inc
NEOGEN Corp
Omega Diagnostics Group PLC
R-Biopharm AG
Romer Labs Division Holding GmbH
Siemens Healthineers AG
Stallergenes Greer Ltd
Thermo Fisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Products and Services
Consumables
Instruments
Services
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Others
By Test
In Vivo Tests
-Skin Prick Tests
-Patch Tests
-Others
In Vitro Tests
By End-User
Diagnostic Laboratories
Hospital-based Laboratories
Academic Research Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)